Open-Label, Parallel-Arm Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Corticosteroid Intra Articular Injection Given 7 Days Before or 7 Days After Lorecivivint Intra-articular Injection Into the Knee of Healthy Volunteers
Latest Information Update: 22 Oct 2021
At a glance
- Drugs Lorecivivint (Primary) ; Triamcinolone (Primary)
- Indications Osteoarthritis
- Focus Pharmacokinetics
- Sponsors Biosplice Therapeutics
- 28 Aug 2021 Results presented at the 2021 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
- 08 Jan 2021 Status changed from recruiting to completed.
- 28 Oct 2020 New trial record